1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Possible MR imaging outcome predictors for interlaminar ESI in terms of the NASS patient-satisfaction scalea
NASS 1 or 2 (n = 37) NASS 3 or 4 (n = 19) P Value Central HIZ or HIVD Present 28 (66.7%) 14 (33.3%) 1.000 Absent 9 (64.3%) 5 (35.7%) Schmorl nodes Present 5 (71.4%) 2 (28.6%) 1.000 Absent 32 (65.3%) 17 (34.7%) Modic type 1 Present 1 (50%) 1 (50%) 1.000 Absent 36 (66.7%) 18 (33.3%) Facet arthropathy Present 9 (24.3%) 7 (36.8%) .362 Absent 28 (75.7%) 12 (63.2%)
a Data are number of patients. Both the NASS patient-satisfaction index and MR imaging were available in 56 patients.